CME Group Other Income (Expense) decreased by 64.0% to $201.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 47.1%, from $136.80M to $201.20M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 10.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.40M | $482.20M | $167.60M | $57.20M | $117.00M | $141.20M | $159.00M | $243.20M | $177.80M | $154.10M | $142.80M | $153.80M | $153.90M | $152.70M | $149.50M | $136.80M | $201.00M | $204.40M | $558.80M | $201.20M |
| QoQ Change | — | +838.1% | -65.2% | -65.9% | +104.5% | +20.7% | +12.6% | +53.0% | -26.9% | -13.3% | -7.3% | +7.7% | +0.1% | -0.8% | -2.1% | -8.5% | +46.9% | +1.7% | +173.4% | -64.0% |
| YoY Change | — | — | — | — | +127.6% | -70.7% | -5.1% | +325.2% | +52.0% | +9.1% | -10.2% | -36.8% | -13.4% | -0.9% | +4.7% | -11.1% | +30.6% | +33.9% | +273.8% | +47.1% |